Cases 1 - 10 of 11
ANACOR PHARMACEUTICALS, INC. et al v. DR. REDDYS LABORATORIES, LTD. et al
as 3:2021cv17831
Plaintiff:
ANACOR PHARMACEUTICALS, INC. and PF PRISM IMB B.V.
Defendant:
DR. REDDYS LABORATORIES, LTD. and DR. REDDYS LABORATORIES, INC.
Cause Of Action: 35 U.S.C. § 271
Anacor Pharmaceuticals, Inc. et al v. Teva Pharmaceuticals Development, Inc. et al
as 1:2021cv01353
Plaintiff:
Anacor Pharmaceuticals, Inc. and PF PRISM IMB B.V.
Defendant:
Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271
Anacor Pharmaceuticals, Inc. et al v. Padagis Israel Pharmaceuticals Ltd. et al
as 1:2021cv01351
Plaintiff:
Anacor Pharmaceuticals, Inc. and PF PRISM IMB B.V.
Defendant:
Padagis Israel Pharmaceuticals Ltd. and Padagis, LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Anacor Pharmaceuticals, Inc. et al v. Macleods Pharmaceuticals Ltd. et al.
as 1:2021cv01350
Plaintiff:
Anacor Pharmaceuticals, Inc. and PF PRISM IMB B.V.
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Anacor Pharmaceuticals, Inc. et al v. Dr. Reddy's Laboratories, Ltd. et al
as 1:2021cv01349
Plaintiff:
Anacor Pharmaceuticals, Inc. and PF PRISM IMB B.V.
Defendant:
Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Anacor Pharmaceuticals, LLC, et al., v. Dr. Reddys Laboratories, Ltd., et al.,
as 1:2021cv01348
Plaintiff:
Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V. and Anacor Pharmaceuticals, LLC
Defendant:
Alkem Laboratories Ltd., Dr. Reddys Laboratories, Ltd., Dr. Reddy's Laboratories, Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00632
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
In re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
as 1:2019md02884
Counter Claimant:
Glasshouse Pharmaceuticals Limited Canada
Not Classified By Court:
Taro Pharmaceuticals U.S.A., Inc., Aurobindo Pharma Limited, Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
Counter Defendant:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al
as 1:2018cv01699
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Anacor Pharmaceuticals, Inc. v. Ascent Pharmaceuticals, Inc. et al
as 1:2018cv01673
Defendant:
Cipla Limited, Perrigo Company plc, Taro Pharmaceuticals U.S.A., Inc. and others
Plaintiff:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
